Oct 21 D&B
Alcohol Use Disorders
Pharmacological Tools for Treatment
Discussed medications: disulfiram, naltrexone, acamprosate.
Treatment Goals
Importance of defining the goal of treatment in psychological conditions.
Contrast of Treatment Approaches:
Disease Concept of Alcoholism: Dominant view that alcoholism is a chronic disease and can only be managed through abstinence.
Authors like Emejelenik in 1960 popularized this concept.
Gamma Drinkers: A classification identified by Jelinek that describes individuals who experience loss of control when drinking.
Addiction as a progressive disease leading to dire consequences if untreated.
Loss of control suggests that addiction leads to inevitable relapse post any drinking.
Harm Reduction Approach: Treatment is more flexible, allowing for controlled drinking as a goal.
Aims to address personal readiness for treatment without the fear of total abstinence.
Suggests that learning to control drinking can be feasible.
Characteristics of Gamma Alcoholics (Jelinek)
Progressive and irreversible disease.
Loss of control post first drink leading to potential bingeing.
Treatment goal focused solely on abstinence leads to limited success.
Controlled Drinking
Advocated as a viable alternative to abstinence-only models.
Provides a way for engaged individuals, especially youth, to seek help.
Suggests that learning to control drinking is itself a conditioned behavior.
Example scenarios:
Drinking to cope with bullying.
Drinking to escape depression.
Cognitive Expectancies in Drinking
Expectancies influence behaviors surrounding drinking.
Research indicates that perceived loss of control may be psychologically instigated rather than purely physiological.
Balanced Placebo Design: Used to discern effects of expectancy versus pharmacological actions in alcohol and controlled drinking studies.
Research by Marlott & Sobel
Studies comparing harm reduction strategies with traditional abstinence-focused therapies.
Findings indicate that teaching controlled drinking techniques can lead to better overall functioning in post-treatment life compared to strict abstinence goals.
Many with controlled drinking approaches maintained more stability in life circumstances.
Treatment as a dual approach—control drinking while addressing underlying reasons for drinking.
Cannabis
Overview of Cannabis Use
Cannabis has been used for thousands of years, with both psychoactive and fibrous applications.
Key cannabinoids: Delta 9 THC and Cannabidiol (CBD).
Historical Context
Marijuana’s introduction in North America primarily as a fiber source, not for psychoactive effects.
Mid to late 1800s saw a rise in hashish use post-French campaigns in Africa.
Marijuana gained popularity during U.S. Prohibition, leading to a rise in clandestine smoking venues (tea rooms).
Criminalization of Cannabis
Harry Anslinger’s pivotal role in the criminalization of marijuana, linking usage predominantly to ethnic minorities.
Classifying cannabis as a narcotic in legislation under the influence of societal prejudices.
Modern Cannabis Use Statistics
As of 2022, around 25% of Canadians reported cannabis use, peaking at 50% in the 20-24 age group.
Strong correlation between heavy use and frequency of use—25% of cannabis users partaking five or more times daily.
Cannabis Products and Methods of Use
Marijuana: Mixture of dried leaves and flower tops, while potency has substantially increased in recent years to an average of 15% THC today.
Hashish: Compressed trichomes extracted from cannabis for a higher THC concentration, around 40%.
Dabs/Shatter: Further refined cannabis products that feature extremely high THC concentrations (over 60%).
Effects of Cannabis
Varying psychoactive effects based on dosage; ranges from euphoria to hallucinations.
Low doses might enhance sexual arousal but higher doses often suppress libido.
Cognitive and Physical Effects
THC influences cognitive abilities, particularly motor performance, impairing activities like driving.
The comparison between THC and alcohol in impairment levels remains significant.
Medical Uses of Cannabis
THC shown to alleviate nausea (antiemetic) and enhance appetite; systemic use noted for chemotherapy patients.
Cannabidiol (CBD) emerging as a superior option for many pain-relieving effects without psychoactive symptoms of THC.
Conclusion
The chapter will continue with further discussion on cannabis, focusing on its effects and medical usage, building on the knowledge accumulated about alcohol previously.